IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $15,376 | -60.6% | 43,932 | -57.7% | 0.00% | – |
Q3 2022 | $39,000 | -18.8% | 103,935 | -0.1% | 0.00% | – |
Q2 2022 | $48,000 | -14.3% | 104,035 | -7.4% | 0.00% | – |
Q1 2022 | $56,000 | +47.4% | 112,397 | +68.0% | 0.00% | – |
Q4 2021 | $38,000 | -55.8% | 66,897 | -19.6% | 0.00% | – |
Q3 2021 | $86,000 | +13.2% | 83,239 | +31.1% | 0.00% | – |
Q2 2021 | $76,000 | -61.0% | 63,512 | -57.8% | 0.00% | – |
Q1 2021 | $195,000 | +178.6% | 150,374 | +685.8% | 0.00% | – |
Q4 2020 | $70,000 | +25.0% | 19,136 | -26.8% | 0.00% | – |
Q3 2020 | $56,000 | +143.5% | 26,125 | +105.0% | 0.00% | – |
Q2 2020 | $23,000 | +15.0% | 12,745 | -14.3% | 0.00% | – |
Q1 2020 | $20,000 | -78.5% | 14,876 | -70.9% | 0.00% | -100.0% |
Q4 2019 | $93,000 | -23.8% | 51,076 | +20.8% | 0.00% | 0.0% |
Q3 2019 | $122,000 | +117.9% | 42,282 | +101.4% | 0.00% | 0.0% |
Q2 2019 | $56,000 | +47.4% | 20,998 | +40.4% | 0.00% | – |
Q1 2019 | $38,000 | +65.2% | 14,956 | +78.7% | 0.00% | – |
Q4 2018 | $23,000 | +35.3% | 8,367 | +341.3% | 0.00% | – |
Q3 2018 | $17,000 | – | 1,896 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |